AI Levodopa Timing Improved UPDRS 4.4 Points in 5 Parkinson Patients
A 2026 open-label feasibility trial involving 5 Parkinson’s disease patients found that app-randomized levodopa timing was associated with a mean 4.4-point improvement on the Unified Parkins…
Read article